TickerFacts.

Cresco Labs Inc. (CRLBF): Capital Expenditures

Annual figures by period end, from SEC filings.

$35.14M
Year ended 2025-12-31
$55.38M2023-12-31: $55.38M2024-12-31: $19.49M2025-12-31: $35.14M$35.14M
2023-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$35.14M+80.3%2026-03-06, From 2025-01-01
2024-12-31$19.49M-64.8%2026-03-06, From 2024-01-01
2023-12-31$55.38Mn/a2025-03-14, From 2023-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Cresco Labs Inc. (CRLBF)2025-12-31$35.14M+80.3%
Ascend Wellness Holdings, Inc. (AAWH)2025-12-31$26.01M+15.4%
Tilray Brands, Inc. (TLRY)2025-05-31$32.92M+12.5%
USANA Health Sciences Inc (USNA)2026-01-03$13.82M+37.2%
Trulieve Cannabis Corp. (TRLV)2025-12-31$44.19M-64.0%
Curaleaf Holdings, Inc. (CURLF)2025-12-31$63.44M-31.4%
Jushi Holdings Inc. (JUSH)2025-12-31$16.09M+241.8%
biote Corp. (BTMD)2025-12-31$5.01M-22.0%
Glass House Brands Inc. (GLAS)2025-12-31$27.18M+164.0%

Compare CRLBF, AAWH, TLRY, USNA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗